These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 36157442)

  • 1. Prolactin and vasoinhibin are endogenous players in diabetic retinopathy revisited.
    Triebel J; Bertsch T; Clapp C
    Front Endocrinol (Lausanne); 2022; 13():994898. PubMed ID: 36157442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulpiride-induced hyperprolactinaemia increases retinal vasoinhibin and protects against diabetic retinopathy in rats.
    Adán-Castro E; Siqueiros-Márquez L; Ramírez-Hernández G; Díaz-Lezama N; Ruíz-Herrera X; Núñez FF; Núñez-Amaro CD; Robles-Osorio ML; Bertsch T; Triebel J; Martínez de la Escalera G; Clapp C
    J Neuroendocrinol; 2022 Apr; 34(4):e13091. PubMed ID: 35078262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levosulpiride Increases the Levels of Prolactin and Antiangiogenic Vasoinhibin in the Vitreous of Patients with Proliferative Diabetic Retinopathy.
    Nuñez-Amaro CD; Moreno-Vega AI; Adan-Castro E; Zamora M; Garcia-Franco R; Ramirez-Neria P; Garcia-Roa M; Villalpando Y; Robles JP; Ramirez-Hernandez G; Lopez M; Sanchez J; Lopez-Star E; Bertsch T; Martinez de la Escalera G; Robles-Osorio ML; Triebel J; Clapp C
    Transl Vis Sci Technol; 2020 Aug; 9(9):27. PubMed ID: 32879783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basis and Design of a Randomized Clinical Trial to Evaluate the Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema.
    Robles-Osorio ML; García-Franco R; Núñez-Amaro CD; Mira-Lorenzo X; Ramírez-Neria P; Hernández W; López-Star E; Bertsch T; Martínez de la Escalera G; Triebel J; Clapp C
    Front Endocrinol (Lausanne); 2018; 9():242. PubMed ID: 29896154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How the diabetic eye loses vision.
    Davidson JA; Ciulla TA; McGill JB; Kles KA; Anderson PW
    Endocrine; 2007 Aug; 32(1):107-16. PubMed ID: 17992608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From Bench to Bedside: Translating the Prolactin/Vasoinhibin Axis.
    Triebel J; Robles-Osorio ML; Garcia-Franco R; Martínez de la Escalera G; Clapp C; Bertsch T
    Front Endocrinol (Lausanne); 2017; 8():342. PubMed ID: 29321761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High levels of serum prolactin protect against diabetic retinopathy by increasing ocular vasoinhibins.
    Arnold E; Rivera JC; Thebault S; Moreno-Páramo D; Quiroz-Mercado H; Quintanar-Stéphano A; Binart N; Martínez de la Escalera G; Clapp C
    Diabetes; 2010 Dec; 59(12):3192-7. PubMed ID: 20823101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Algorithms for Diagnosis of Diabetic Retinopathy and Diabetic Macula Edema- A Review.
    Suriyasekeran K; Santhanamahalingam S; Duraisamy M
    Adv Exp Med Biol; 2021; 1307():357-373. PubMed ID: 32166636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HGR motif is the antiangiogenic determinant of vasoinhibin: implications for a therapeutic orally active oligopeptide.
    Robles JP; Zamora M; Siqueiros-Marquez L; Adan-Castro E; Ramirez-Hernandez G; Nuñez FF; Lopez-Casillas F; Millar RP; Bertsch T; Martínez de la Escalera G; Triebel J; Clapp C
    Angiogenesis; 2022 Feb; 25(1):57-70. PubMed ID: 34097181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin stimulates the vascularisation of the retina in newborn mice under hyperoxia conditions.
    Vázquez-Membrillo M; Siqueiros-Márquez L; Núñez FF; Díaz-Lezama N; Adán-Castro E; Ramírez-Hernández G; Adán N; Macotela Y; Martínez de la Escalera G; Clapp C
    J Neuroendocrinol; 2020 Nov; 32(11):e12858. PubMed ID: 32449569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The status of diabetic retinopathy and diabetic macular edema in patients with type 2 diabetes: a survey from Beixinjing District of Shanghai city in China.
    Wang N; Xu X; Zou H; Zhu J; Wang W; Ho PC
    Ophthalmologica; 2008; 222(1):32-6. PubMed ID: 18097178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of prolactin-related vasoinhibin in sera from patients with diabetic retinopathy.
    Triebel J; Huefner M; Ramadori G
    Eur J Endocrinol; 2009 Aug; 161(2):345-53. PubMed ID: 19477896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasoinhibin gene transfer by adenoassociated virus type 2 protects against VEGF- and diabetes-induced retinal vasopermeability.
    Ramírez M; Wu Z; Moreno-Carranza B; Jeziorski MC; Arnold E; Díaz-Lezama N; Martínez de la Escalera G; Colosi P; Clapp C
    Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8944-50. PubMed ID: 22003113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical coherence tomography for the detection of early macular edema in diabetic patients with retinopathy.
    Koleva-Georgieva DN; Sivkova NP
    Folia Med (Plovdiv); 2010; 52(1):40-8. PubMed ID: 20380286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasoinhibins prevent retinal vasopermeability associated with diabetic retinopathy in rats via protein phosphatase 2A-dependent eNOS inactivation.
    García C; Aranda J; Arnold E; Thébault S; Macotela Y; López-Casillas F; Mendoza V; Quiroz-Mercado H; Hernández-Montiel HL; Lin SH; de la Escalera GM; Clapp C
    J Clin Invest; 2008 Jun; 118(6):2291-300. PubMed ID: 18497878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing disutility associated with diabetic retinopathy, diabetic macular oedema and associated visual impairment using the Vision and Quality of Life Index.
    Fenwick EK; Xie J; Pesudovs K; Ratcliffe J; Chiang PP; Finger RP; Lamoureux EL
    Clin Exp Optom; 2012 May; 95(3):362-70. PubMed ID: 22537275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrophy of the central neuroretina in patients treated for diabetic macular edema.
    Karst SG; Schuster M; Mitsch C; Meyer EL; Kundi M; Scholda C; Schmidt-Erfurth UM
    Acta Ophthalmol; 2019 Dec; 97(8):e1054-e1061. PubMed ID: 31228332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Diabetic Macular Edema on Repeatability of Retinal Nerve Fiber Layer Thickness Measurements at the Macular and Peripapillary Area Using Swept-Source Optical Coherence Tomography.
    Min JK; Lee S; Kim JS; Woo JM; Yang HS
    Curr Eye Res; 2017 Feb; 42(2):307-314. PubMed ID: 27347610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Handheld Retinal Imaging with ETDRS 7-Standard Field Photography for Diabetic Retinopathy and Diabetic Macular Edema.
    Salongcay RP; Aquino LAC; Salva CMG; Saunar AV; Alog GP; Sun JK; Peto T; Silva PS
    Ophthalmol Retina; 2022 Jul; 6(7):548-556. PubMed ID: 35278726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. En Face Doppler Optical Coherence Tomography Measurement of Total Retinal Blood Flow in Diabetic Retinopathy and Diabetic Macular Edema.
    Lee B; Novais EA; Waheed NK; Adhi M; de Carlo TE; Cole ED; Moult EM; Choi W; Lane M; Baumal CR; Duker JS; Fujimoto JG
    JAMA Ophthalmol; 2017 Mar; 135(3):244-251. PubMed ID: 28196198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.